Release Date: 10/07/09 09:27 Summary: Response to ASX Query - Change of Director's Interest Notice Price Sensitive: No Download Document 90.75KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%